TRPV2 and breast carcinoma: The antimicrobial peptide LL-37 promotes the migration of breast cancer cells via PI3K/AKT signaling and increases intracellular Ca2+ levels via Transient Receptor Potential Cation Channel Subfamily V Member 2 (TRPV2).